<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-190 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-190</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-190</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-10.html">extraction-schema-10</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <p><strong>Paper ID:</strong> paper-308d8504e83610df71690c0b8f4c1b629e03a3c5</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/308d8504e83610df71690c0b8f4c1b629e03a3c5" target="_blank">Thymoma and autoimmunity</a></p>
                <p><strong>Paper Venue:</strong> Cellular & Molecular Immunology</p>
                <p><strong>Paper TL;DR:</strong> The current scientific evidence detailing the various interactions between thymoma and autoimmune diseases, including myasthenia gravis, systemic lupus erythematosus, inappropriate antidiuretic hormone secretion, pure red cell aplasia, pernicious anemia, pemphigus and autoimmune thyroid diseases is compiled.</p>
                <p><strong>Cost:</strong> 0.018</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e190.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e190.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Autoimmunity (general)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Autoimmune conditions associated with thymoma</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Overview of the frequency and general clinical association between thymoma and a variety of autoimmune/paraneoplastic diseases; thymoma commonly co-occurs with autoimmunity and can present with multiple simultaneous autoimmune disorders.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Various (general summary)</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td>In 30% of patients with thymoma an autoimmune condition will be diagnosed either comorbidly or after thymectomy; up to 50% of thymoma patients with autoimmunity may have two concomitant autoimmune diseases.</td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>General concept: tumor-induced disruption of thymic central tolerance leading to export of autoreactive T cells and secondary activation of B cells; specific mechanisms discussed include (1) escape of immature thymocytes that avoided medullary negative selection, (2) neoplastic/genetic alterations in thymic epithelial cells affecting selection (e.g., reduced HLA-DR), and (3) combined cellular-to-humoral deregulation where autoreactive T cells help B cells produce autoantibodies.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td>Frequent findings across studies: intrathymic germinal centers, altered T-cell subset composition in blood, high thymocyte proliferation (Ki67), presence of immature thymocytes (TdT+, CD4+/CD8+ double-positive), reduced mature CD4+ T-cell fraction in thymic tissue, and presence of disease-specific autoantibodies in sera.</td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td>Autoimmune conditions may be present at diagnosis or may appear after thymectomy; timing varies by disease and individual reports.</td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td>Thymectomy can be beneficial for some comorbid autoimmune diseases (reported remissions in certain conditions), but autoimmune disease may also appear after thymectomy in some case reports.</td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td>No consistent single demographic predictor reported for all autoimmune comorbidities; some disease-specific associations (see disease-level entries).</td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td>Intrathymic germinal centers, neoplastic epithelial changes, increased thymocyte proliferation (Ki67 35–80%), presence of immature cortical thymocytes and impaired medullary selection.</td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td>Export of immature/autoreactive thymocytes (CD4+/CD8+ double-positive), reduced mature CD4+ T cells in tumor tissue, aberrant autoimmune CD4 T cells, large numbers of CD8 T cells with impaired tolerance in some models.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e190.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e190.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>MG</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Myasthenia gravis</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Neuromuscular autoimmune disease strongly associated with thymoma; autoantibodies (primarily anti-acetylcholine receptor) impair neuromuscular transmission causing fatigable weakness.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Myasthenia gravis (MG)</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td>Among MG patients, ~75% have thymic abnormality; thymoma is present in ~15% of MG patients (these percentages are given from MG-patient cohorts rather than percent of thymoma patients who have MG). No explicit percent of thymoma patients who develop MG is provided in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td>WHO types B1 and B2 are specifically linked to MG in this review (associated with many double-positive thymocytes).</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Combined cellular-humoral deregulation and intrathymic generation of autoreactive cells: (1) thymoma produces immature/aberrant thymocytes that escape medullary negative selection (immature T-cell 'escape' theory); (2) intrathymic germinal centers in thymoma help generate and/or sustain anti-AChR autoantibody-producing B cells; (3) neoplastic epithelial changes (reduced HLA-DR expression) may alter positive selection and favor autoreactivity; overall a two-step model: export of autoreactive T cells followed by CD4 T cell help to B cells to produce autoantibodies.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td>Presence of intrathymic germinal centers; thymomas (especially B1/B2) contain many CD4+/CD8+ double-positive (immature) thymocytes; thymoma tissue shows high Ki67 proliferation (35–80% in referenced study) and reduced mature CD4+ T cells compared with normal thymus; aberrant autoimmune CD4 T cells documented; changes in peripheral T-cell subset composition reported in referenced studies.</td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td>Anti-acetylcholine receptor (anti-AChR) antibodies; subgroup-associated autoantibodies including anti-ryanodine receptor (with myositis/myocarditis), voltage-gated/calcium channel antibodies (with neuromyotonia), and anti-titin or calcium channel antibodies in other subgroups; striational antibodies also referenced in historical context.</td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td>MG can present concurrently with thymoma; cases described across wide age range including infancy. Pre-thymectomy anti-AChR antibody levels were reported as a risk factor for post-thymectomy MG in one cited study.</td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td>Thymectomy in thymoma-associated MG is associated with clinical improvement and reduction of anti-AChR antibody titers in reported series; course of disease changes after resection according to cited studies.</td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td>Okumura et al. reported a majority female cohort overall, but no sex differences between thymoma-associated MG and non-thymoma MG; HLA subtypes (HLA-A24 and HLA-B8) are noted as predictive factors for MG and linked to thymoma in cited studies; MG–thymoma association seen across ages.</td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td>Intrathymic germinal centers characteristic of thymoma; neoplastic epithelial cells with reduced HLA-DR expression; cortical thymocytes with markers of immaturity (TdT+, T6+, CD4+/CD8+ double-positive); impaired medullary selection suspected.</td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td>Increased immature CD4+/CD8+ double-positive thymocytes in B1/B2 thymomas; reduced mature CD4+ T-cell fraction compared to normal thymus; presence of autoreactive/aberrant CD4 T cells; export of autoreactive CD8 T cells theorized in combined model.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td>Compared to normal thymus: thymomas have higher Ki67 (35–80%) and fewer mature CD4+ T cells; compared to non-thymoma MG, Okumura et al. found no sex differences but linked specific thymoma histotypes (B1/B2) and intrathymic abnormalities to thymoma-associated MG; thymectomy reduces anti-AChR titers in thymoma-associated MG.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e190.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e190.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>SLE</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Systemic lupus erythematosus</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Systemic autoimmune disease that co-occurs with thymoma in a minority of cases; association supported by epidemiological studies and case reports including steroid-resistant SLE responding to thymomectomy.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Systemic lupus erythematosus (SLE)</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td>Co-occurrence estimated at ~1.5–2% in clinical epidemiological studies and up to ~10% in studies where thymus biopsies were reviewed.</td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Likely related to thymic failure of central tolerance (export of autoreactive T cells) and broader immune dysregulation induced by thymoma; exact mechanisms not fully elucidated but thymectomy-induced changes and thymoma-mediated impaired selection are implicated.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td>Clinical reports note more frequent polyarthritis, skin rashes, fever and cytopenias in SLE patients with thymoma; remission of steroid-resistant SLE after thymomectomy in some cases suggests tumor-driven immunopathology. Specific mechanistic immunologic assays are not detailed in the review.</td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td>SLE can be comorbid with thymoma or, in case reports, may appear after thymectomy; late-age-onset SLE should prompt consideration of thymoma according to a cited meta-analysis.</td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td>Thymomectomy has been reported to induce remission in some steroid-resistant SLE cases, but there are also reports of SLE developing after thymectomy (mixed outcomes reported).</td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td>Reports indicate SLE with thymoma may present at later age; some series associated the comorbidity with worse prognosis. No consistent demographic risk profile provided.</td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td>Meta-analysis and case reviews suggest non-incidental association; clinical series report different manifestations (e.g., more cytopenias) in SLE patients with thymoma, but no systematic immunological control comparison is detailed in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e190.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e190.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PRCA</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Acquired pure red cell aplasia (PRCA)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A chronic autoimmune form of PRCA can be associated with thymoma, where T-cell–mediated damage to erythroid progenitors leads to severe anemia.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Acquired pure red cell aplasia (PRCA)</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td>Estimated that ~5% of thymomas coexist with pure red cell aplasia.</td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>T cell–mediated damage to erythroid progenitors/precursor cells driven by thymoma-associated immune dysregulation (cellular autoimmune mechanism).</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td>Histological investigations reported small germinal centers and lymphoid aggregation in bone marrow of affected patients, suggesting interplay between cellular and humoral alterations; specific T-cell phenotypes are not detailed in the review.</td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td>PRCA may be chronic and coexist with thymoma; timing relative to thymectomy not systematically detailed here.</td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td>Damage appears T cell–mediated (review cites evidence supporting T-cell cytotoxicity against erythroid lineage).</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e190.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e190.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Bullous dermatoses</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Autoimmune bullous dermatoses (pemphigus vulgaris, paraneoplastic pemphigus, bullous pemphigoid)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Group of antibody-mediated blistering skin diseases that have been reported in association with thymoma, with case reports of improvement after tumor resection.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Pemphigus (including paraneoplastic pemphigus) and bullous pemphigoid</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td>More than 20 cases of pemphigus associated with thymoma have been documented in the literature (no percentage prevalence provided).</td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Likely humoral autoimmunity driven or supported by intrathymic germinal centers and export of autoreactive T cells that provide help for pathogenic autoantibody production; tumor removal has led to regression in some reports, implicating thymoma-driven autoantibody generation.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td>Case reports of paraneoplastic pemphigus regression after thymoma resection imply a tumor-dependent autoantibody process; specific immunologic assays not detailed here.</td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td>Reported concurrent with thymoma; regression after thymoma resection in case report(s).</td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td>Resection of thymoma has been reported to result in regression of bullous dermatoses in at least one documented case.</td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e190.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e190.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>SIADH</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Syndrome of inappropriate antidiuretic hormone secretion (SIADH) associated with thymoma</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Hyponatremic paraneoplastic syndrome reported in association with thymic tumors; recent reports suggest possible autoimmune mechanisms though pathogenesis remains unclear.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>SIADH (paraneoplastic)</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Proposed autoimmune link but specific mechanisms remain to be elucidated; associations have been reported in case series linking SIADH with mediastinal/thymic masses and with MG-associated thymoma.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td>Several cases demonstrated SIADH co-diagnosed with mediastinal mass/thymoma or with MG associated with thymoma.</td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e190.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e190.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Pernicious anemia</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Pernicious anemia</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Autoimmune gastritis causing vitamin B12 deficiency has been reported in association with thymoma and hypogammaglobulinemia in sparse case reports.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Pernicious anemia</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Not detailed in the review; presumed autoimmune B-cell mediated gastritis possibly linked to thymoma-associated immune dysregulation.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e190.7">
                <h3 class="extraction-instance">Extracted Data Instance 7 (e190.7)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Autoimmune cytopenias</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Autoimmune cytopenias (thrombocytopenia, neutropenia, autoimmune hemolytic anemia)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Immune-mediated reductions of blood cell lines have been reported in association with thymoma, often alongside other paraneoplastic autoimmune phenomena.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Thrombocytopenia, neutropenia, autoimmune hemolytic anemia</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Likely immune-mediated (cellular and/or humoral) destruction of blood elements resulting from thymoma-related breakdown in self-tolerance; specific mechanisms not detailed in review.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td>Case reports of autoimmune hemolytic anemia and other cytopenias co-occurring with thymoma are cited; bone marrow/immune alterations noted in PRCA cases suggest interplay between cellular and humoral immunity.</td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td>Reported as coexisting with thymoma in case reports; timing relative to thymectomy not systematically provided.</td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e190.8">
                <h3 class="extraction-instance">Extracted Data Instance 8 (e190.8)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Autoimmune thyroid disease</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Autoimmune thyroid diseases (including Graves' disease)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Thymic tumors (including invasive thymoma) have been reported in association with autoimmune thyroid disease such as Graves' disease in case reports.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma and autoimmunity</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Autoimmune thyroid disease (Graves' disease)</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td>Invasive thymoma reported in association with Graves' disease</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Not specified in this review; presumed tumor-driven breakdown of central tolerance enabling thyroid autoimmunity.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td>Reported co-occurrence in case reports; may occur with other paraneoplastic features such as SIADH and MG.</td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma and autoimmunity', 'publication_date_yy_mm': '2011-02'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis <em>(Rating: 2)</em></li>
                <li>Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease <em>(Rating: 2)</em></li>
                <li>Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience <em>(Rating: 2)</em></li>
                <li>A meta-analysis of thymoma-associated systemic lupus erythematosus from 1975-2008 worldwide <em>(Rating: 2)</em></li>
                <li>Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia <em>(Rating: 2)</em></li>
                <li>Immunohistochemical evidence of active thymocyte proliferation in thymoma. Its possible role in the pathogenesis of autoimmune diseases. <em>(Rating: 2)</em></li>
                <li>Correlation of thymic pathology with HLA in myasthenia gravis <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>